These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27024960)

  • 41. Non-IgE-Mediated Drug Hypersensitivity Reactions.
    Joshi SR; Khan DA
    Curr Allergy Asthma Rep; 2021 Aug; 21(7):41. PubMed ID: 34463914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
    White KD; Chung WH; Hung SI; Mallal S; Phillips EJ
    J Allergy Clin Immunol; 2015 Aug; 136(2):219-34; quiz 235. PubMed ID: 26254049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human leukocyte antigen-associated drug hypersensitivity.
    Illing PT; Vivian JP; Purcell AW; Rossjohn J; McCluskey J
    Curr Opin Immunol; 2013 Feb; 25(1):81-9. PubMed ID: 23141566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
    Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
    Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
    Yip VL; Alfirevic A; Pirmohamed M
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):165-75. PubMed ID: 24777842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenomics of Allopurinol and Sulfamethoxazole/Trimethoprim: Case Series and Review of the Literature.
    Ikediobi O; Schneider JA
    J Pers Med; 2021 Jan; 11(2):. PubMed ID: 33530463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA and drug-induced toxicity.
    Phillips EJ; Mallal SA
    Curr Opin Mol Ther; 2009 Jun; 11(3):231-42. PubMed ID: 19479656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Severe delayed drug hypersensitivity reactions].
    Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C
    Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Comprehensive Review of
    Kloypan C; Koomdee N; Satapornpong P; Tempark T; Biswas M; Sukasem C
    Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.
    Yun J; Adam J; Yerly D; Pichler WJ
    Allergy; 2012 Nov; 67(11):1338-46. PubMed ID: 22943588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
    Alfirevic A; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.
    Deshpande P; Hertzman RJ; Palubinsky AM; Giles JB; Karnes JH; Gibson A; Phillips EJ
    Clin Pharmacol Ther; 2021 Sep; 110(3):607-615. PubMed ID: 34143437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxic epidermal necrolysis: the year in review.
    Lee HY; Chung WH
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):330-6. PubMed ID: 23799330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
    Pirmohamed M; Ostrov DA; Park BK
    J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-induced liver injury with skin reactions: Drugs and host risk factors, clinical phenotypes and prognosis.
    Devarbhavi H; Raj S
    Liver Int; 2019 May; 39(5):802-811. PubMed ID: 30515930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
    Ghislain PD; Roujeau JC
    Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms.
    Dao RL; Su SC; Chung WH
    Asia Pac Allergy; 2015 Apr; 5(2):59-67. PubMed ID: 25938070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
    Neuman MG; Cohen L; Nanau RM; Hwang PA
    Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.